172@29@16@18!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Brooks Laboratories Ltd.

BSE: 533543 | NSE: BROOKS |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.
Series: BE | ISIN: INE650L01011 | SECTOR: Pharmaceuticals

BSE Live

Oct 20, 16:00
60.95 2.10 (3.57%)
Volume
AVERAGE VOLUME
5-Day
16,813
10-Day
25,685
30-Day
20,290
6,427
  • Prev. Close

    58.85

  • Open Price

    60.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 20, 15:48
61.20 2.75 (4.70%)
Volume
AVERAGE VOLUME
5-Day
24,567
10-Day
56,517
30-Day
58,280
17,041
  • Prev. Close

    58.45

  • Open Price

    59.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Key Financial Ratios of Brooks Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
Per Share Ratios  
Basic EPS (Rs.) -13.84 -9.20 -8.53 1.03 6.57  
Diluted EPS (Rs.) -13.84 -9.20 -8.53 1.03 6.57  
Cash EPS (Rs.) -7.18 -5.13 -4.55 2.06 7.29  
Book Value [ExclRevalReserve]/Share (Rs.) 39.84 64.96 70.72 79.25 75.40  
Book Value [InclRevalReserve]/Share (Rs.) 39.84 64.96 70.72 79.25 75.40  
Dividend / Share(Rs.) 0.00 0.00 0.00 0.00 0.00  
Revenue from Operations/Share (Rs.) 28.21 34.00 34.42 35.55 49.43  
PBDIT/Share (Rs.) -1.42 -3.39 -5.37 3.19 7.81  
PBIT/Share (Rs.) -4.11 -7.40 -9.35 2.16 7.10  
PBT/Share (Rs.) -5.47 -9.23 -10.83 1.53 6.68  
Net Profit/Share (Rs.) -9.87 -9.15 -8.53 1.03 6.57  
Profitability Ratios  
PBDIT Margin (%) -5.04 -9.96 -15.58 8.97 15.80  
PBIT Margin (%) -14.58 -21.77 -27.15 6.06 14.35  
PBT Margin (%) -19.39 -27.16 -31.47 4.31 13.52  
Net Profit Margin (%) -34.97 -26.90 -24.79 2.89 13.29  
Return on Networth / Equity (%) -24.76 -14.08 -12.06 1.29 8.71  
Return on Capital Employed (%) -9.06 -9.94 -11.44 1.19 8.53  
Return on Assets (%) -15.44 -8.81 -7.99 1.01 6.97  
Total Debt/Equity (X) 0.24 0.27 0.22 0.10 0.05  
Asset Turnover Ratio (%) 44.14 32.76 32.26 35.05 52.45  
Liquidity Ratios  
Current Ratio (X) 0.83 0.67 0.76 0.90 1.17  
Quick Ratio (X) 0.53 0.46 0.48 0.58 0.93  
Inventory Turnover Ratio (X) 5.06 5.47 4.88 7.47 11.96  
Dividend Payout Ratio (NP) (%) 0.00 0.00 0.00 0.00 0.00  
Dividend Payout Ratio (CP) (%) 0.00 0.00 0.00 0.00 0.00  
Earnings Retention Ratio (%) 0.00 0.00 0.00 0.00 0.00  
Cash Earnings Retention Ratio (%) 0.00 0.00 0.00 0.00 0.00  
Valuation Ratios  
Enterprise Value (Cr.) 60.28 111.06 152.70 230.15 142.52  
EV/Net Operating Revenue (X) 0.86 2.02 2.74 4.00 1.78  
EV/EBITDA (X) -17.14 -20.24 -17.58 44.57 11.27  
MarketCap/Net Operating Revenue (X) 0.54 1.57 2.32 3.81 1.74  
Retention Ratios (%) 0.00 0.00 0.00 0.00 0.00  
Price/BV (X) 0.38 0.82 1.13 1.71 1.14  
Price/Net Operating Revenue 0.54 1.57 2.32 3.81 1.74  
Earnings Yield -0.64 -0.17 -0.11 0.01 0.08  
Source : Dion Global Solutions Limited